The immune function differences and high-risk human papillomavirus infection in the progress of cervical cancer

被引:0
作者
Li, Changdong [1 ]
Ma, Cui [2 ]
Zhang, Weiyuan [2 ]
Wang, Jiandong [2 ]
机构
[1] Dept Gynecol & Family Planning, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Gynecol Oncol, Beijing 100026, Peoples R China
关键词
Cervical cancer; Cervical intraepithelial neoplasia; Immune function; High-risk HPV; T-CELLS; DENDRITIC CELLS; RESPONSES; CARCINOMA; VACCINES; DNA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Investigation: To study the differences immune function in normal cervix, cervical intraepithelial neoplasia (CIN) and cervical cancer tissue, and study the relationship between human papillomavirus (ITV) infection and cervical local immune function. Materials and Methods: This study determined the form, quantity, distribution, and intensity of CD4(+)Th cells, S-100(+) dendritic cells (DCs) and CD57(+)NK cells in the normal cervical tissue, CIN cervical tissue, and cervical cancer by histopathological and image analyses. Results: The immune function was differences in the progress of cancer genesis. The numbers of the CD4(+) Th cells, S-100(+) DCs, and CD57(+)NK cells increased with the progress of the disease in CIN, but when cancer occurred, immune cells decreased in local cervical tissue. Conclusion: From lesion precancerous to infiltrating carcinoma, the form, quantity, and intensity of expression of immune cells changed, which may indicate that the cervical local immune function has changed. Furthermore, high-risk HPV infections are more active in local immune function.
引用
收藏
页码:557 / 561
页数:5
相关论文
共 22 条
[1]  
Ancuta E, 2009, ROM J MORPHOL EMBRYO, V50, P651
[2]  
Bedoya AM, 2012, CANC MICROENVIRON
[3]  
Bhairavabhotla RK, 2007, INDIAN J BIOCHEM BIO, V44, P350
[4]   Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particles [J].
Bontkes, HJ ;
Ruizendaal, JJ ;
Kramer, D ;
Meijer, CJLM ;
Hooijberg, E .
GYNECOLOGIC ONCOLOGY, 2005, 96 (03) :897-901
[5]   Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology:: a meta-analysis [J].
de Sanjose, Silvia ;
Diaz, Mireia ;
Castellsague, Xavier ;
Clifford, Gary ;
Bruni, Laia ;
Munoz, Nubia ;
Bosch, F. Xavier .
LANCET INFECTIOUS DISEASES, 2007, 7 (07) :453-459
[6]  
Delvenne P, 2011, Bull Mem Acad R Med Belg, V166, P28
[7]  
Duggan Maire A, 2002, Gan To Kagaku Ryoho, V29 Suppl 1, P176
[8]   Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines [J].
Einstein, Mark H. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (04) :443-451
[9]   Recombinant Lipidated HPV E7 Induces a Th-1-Biased Immune Response and Protective Immunity against Cervical Cancer in a Mouse Model [J].
Huang, Chiung-Yi ;
Chen, Jeremy J. W. ;
Shen, Kuan-Yin ;
Chang, Li-Sheng ;
Yeh, Yi-Chen ;
Chen, I-Hua ;
Chong, Pele ;
Liu, Shih-Jen ;
Leng, Chih-Hsiang .
PLOS ONE, 2012, 7 (07)
[10]  
Kalinski P, 2013, EXPERT REV VACCINES, V12, P285, DOI [10.1586/erv.13.22, 10.1586/ERV.13.22]